CCNA2 and cancer: The tumor suppressor p53 is known to block cancer development by suppressing various types of cyclin/CDK complexes such as cyclin D-CDK4/6, cyclin A/E-CDK2, and cyclin B-CDK1 through upregulation of the CDK inhibitor p21 [48].